CANNABIS GROWTH FUND

Providing investors access to a growing, emerging industry via a
professionally managed mutual fund

Providing investors access to a growing, emerging industry via a professionally managed mutual fund

Overview

The Cannabis Growth Fund is one of the first open-end mutual funds to invest primarily in companies related to the cannabis industry.

Strategy

The Fund plans to invest primarily in exchange listed equity securities of companies in the cannabis industry. These companies are located around the globe and engaged exclusively in legal activities under national and local laws, including U.S. federal and state law, as applicable.1,2 Many companies that the Fund seeks to hold legally participate in activities including agriculture technology, biotechnology, cultivation and retail, products and extracts, industry hemp, and ancillary products and services that complement the cannabis industry. Diversified across various subsectors to provide broad-based exposure, the Fund helps investors capitalize on the fast-growing, innovative cannabis industry.

Why Professional Management?

Today the cannabis industry is growing quickly, with a universe of over 75 small-, mid- and large-cap companies that participate in medicinal or recreational use of cannabis. As this new industry changes and expands, we believe active management has advantages over purchasing individual companies or a passive ETF. In our opinion, knowledgeable and dedicated professionals help investors mitigate inherent volatility and identify favorable growth opportunities, such as initial public offerings. The Fund also has the flexibility to use options in an attempt to enhance the Fund’s return and reduce volatility.

Asset Allocation and the Cannabis Growth Fund

The Fund is a specialty and actively managed portfolio focused on investing in the cannabis industry, providing potentially small-cap, aggressive growth exposure. When including the Fund in an overall portfolio, investors should consider their long-term objectives and goals and place the Fund appropriately within an equity portfolio.3

1 The companies are engaged exclusively in legal activities under national and local laws, including U.S. federal and state law, as applicable. Controlled substance legislation differs between countries, which may limit the ability of cannabis industry companies to sell their products.

2 Pronouncements from the current Administration suggest the Department of Justice may take action against states to prevent them from implementing laws that authorize medical marijuana use, possession, distribution, and cultivation. This action may have a material effect on investment in companies involved in the cannabis industry.

3 Fund investments will be concentrated in an industry or group of industries, and the value of Fund shares may rise and fall more than more diversified funds.

You don’t get an
opportunity every day
to participate in the
very early stages of
global industry and
that is what is
happening now”

– Cam Battley, Chief Corporate Officer, Aurora Cannabis*

An aggressive-growth
Component of an Equity Portfolio

aggresive-compnent-equity-portfolio
Asset allocation does not guarantee a profit or protect against
a loss in declining markets.
DAILY PRICES   as of 9/23/2020

Investor Class
CANNX NAV: $3.73    Change: $-0.19

Class I
CANIX NAV: $3.71    Change: $-0.19

LITERATURE CENTER

Portfolio Management

Korey-Bauer
KOREY BAUER, CMT ®
Portfolio Manager and
Managing Director

Over 8 years of experience